Owner Alexza Pharmaceuticals, Inc.

Inventors Rabinowitz, Joshua D.; Zaffaroni, Alejandro C.

Agent Davies Collison Cave

Pub. Number AU-B-2002310015

PCT Number PCT/US02/16118

PCT Pub. Number WO2002/094236

Priority 60/317,479 05.09.01 US; 60/294,203 24.05.01 US

Filing date 20 May 2002

Wipo publication date 3 December 2002

Acceptance publication date 4 September 2008

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/19 (2006.01)

A61K 31/192 (2006.01)

A61K 31/216 (2006.01)

A61K 31/27 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/404 (2006.01)

A61K 31/4045 (2006.01)

A61K 31/405 (2006.01)

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/437 (2006.01)

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine